SCHEMBL9379837

SCHEMBL9379837

O=C1CN=C(c2ccc(Cl)cc2)c2cc(I)ccc2N1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE4D Q08499 2/20 0.68
▸ CNR1 P21554 1/20 0.68
▸ NTSR1 P30989 1/20 0.68
▸ OPRK1 P41145 1/20 0.68
▸ GABRA1 P14867 5/20 0.56
▸ GABRA5 P31644 5/20 0.56
▸ GABRA3 P34903 5/20 0.56
▸ GABRA2 P47869 5/20 0.56
▸ GABRB2 P47870 5/20 0.56
▸ GABRG2 P18507 4/20 0.56
▸ GABRB3 P28472 4/20 0.56
▸ GABRP O00591 3/20 0.56
▸ GABRD O14764 3/20 0.56
▸ GABRB1 P18505 3/20 0.56
▸ GABRA4 P48169 3/20 0.56
▸ GABRE P78334 3/20 0.56
▸ GABRA6 Q16445 3/20 0.56
▸ GABRG1 Q8N1C3 3/20 0.56
▸ GABRG3 Q99928 3/20 0.56
▸ GABRQ Q9UN88 3/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10747106 0.86 PDE4D (0.71) PDE4DCNR1NTSR1OPRK1GABRA1
SCHEMBL9383698 0.84 CHRM1 (0.68) PDE4DCNR1NTSR1OPRK1GABRA1
SCHEMBL21129434 0.84 PDE4D (0.68) PDE4DCNR1NTSR1OPRK1GABRA1
SCHEMBL10149934 0.82 PDE4D (0.76) PDE4DCNR1NTSR1OPRK1GABRA1
Nordazepam SCHEMBL29354494 0.81 PDE4D (1.00) PDE4DCNR1NTSR1OPRK1GABRA1
Nordazepam SCHEMBL31000330 0.81 PDE4D (1.00) PDE4DCNR1NTSR1OPRK1GABRA1
Nordazepam SCHEMBL78453 0.81 PDE4D (1.00) PDE4DCNR1NTSR1OPRK1GABRA1
Nordazepam SCHEMBL8090999 0.81 PDE4D (1.00) PDE4DCNR1NTSR1OPRK1GABRA1
SCHEMBL15704731 0.81 PDE4D (0.64) PDE4DCNR1NTSR1OPRK1GABRA1
SCHEMBL11543658 0.81 GABRA1 (0.78) PDE4DCNR1NTSR1OPRK1GABRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0320992-B1 Triazolodiazepine derivatives HOFFMANN LA ROCHE (CH) 1994-07-27 — — EP disclosed
US-4959361-A Triazolo(4,3-A)(1,4)benzodiazepines and thieno (3,2-F)(1,2,4)triazolo(4,3-A)(1,4)diazepine compounds which have useful activity as platelet activating factor (PAF) antagonists HOFFMANN-LA ROCHE INC. (US) 1990-09-25 — — US disclosed
EP-0320992-A2 Triazolodiazepine derivatives F. HOFFMANN-LA ROCHE AG (CH) 1989-06-21 — — EP disclosed
Send feedback